The Migraine Relief Center Blog

Here’s the latest from the Migraine Relief Center

Keep up with the doctors, patients, treatments—and results—from all our locations.

Migraine Relief Center

Recent Posts

A Review: Three Studies of the Effects of Cannabis on Migraines

By Migraine Relief Center on December 9, 2019

While the popularity of cannabidiol (CBD) continues to soar, there are still few studies available with data to support its use. Now that industrial hemp farming is legal, studies of hemp oil and CBD on migraines may become more available. Confounding some of the efforts is the fact that, while CBD is legal at the federal level, it is still illegal in some states. However, the trend appears to be toward the legalization of CBD in certain forms.

Read More

Digital Media and Migraines - The New Trigger?

By Migraine Relief Center on November 25, 2019

Up to 90% of migraineurs are sensitive to light, either before, during, or after a migraine attack.  That light sensitivity can be enough to trigger a migraine, and most digital media is light-based. So it makes sense that the use of digital devices and consuming digital media could trigger migraines in susceptible people. 

Read More

FDA Approval of Reyvow (rasmitidan) for Migraines

By Migraine Relief Center on November 11, 2019

People suffering from acute migraines will soon have another rescue medication at their disposal - The FDA approved Reyvow (lasmiditan hemisuccinate). The US Drug Enforcement Administration (DEA) has 90 days to review the drug to determine if it will be classified as a controlled substance. Once that three-month period is complete, the maker, Eli Lilly, and Company expect it to be available at retail pharmacies.

Read More

Ketamine and Migraines – A Wonder Drug?

By Migraine Relief Center on October 25, 2019

When a migraine doesn't respond to any other treatment, ketamine may offer relief. Operating differently than opioids, non-steroidal anti-inflammatories, and triptans, ketamine is increasingly available to treat chronic pain, migraine, and other health issues.

Read More

A Review of Electrical Nerve Stimulation

By Migraine Relief Center on October 11, 2019

 

Within the past decade, electrical nerve stimulation has been introduced as a potential non-drug treatment for individuals suffering migraines or cluster headaches. The approach varies slightly between techniques, and depending on the method, can be invasive or non-invasive.

Read More

Do You Have Episodic Migraines?

By Migraine Relief Center on September 30, 2019

Migraines come in several flavors, but one of the primary classifications is that of episodic migraine. Episodic migraines differ from chronic migraine disorder and may respond better to some treatments than chronic migraines.

Read More

What Are the Risks of Opioid Use for Migraineurs in This Age of Crisis?

By Migraine Relief Center on August 21, 2019

“Given the opioid epidemic in the U.S. and the high prevalence of opioid use in migraine patients shown in our study, especially those with chronic migraine, our results suggest that improved management of treatment is needed to optimize care.” - Justin S. Yu, PharmS, Allergan

Read More

Are There Benefits to Migraines?

By Migraine Relief Center on July 25, 2019

After reading the title to this post, you are probably wondering how anyone could possibly think there is an advantage to having migraines. If you are suffering one right now, it probably won’t make you feel better, but sometimes knowing that there may be something good out of all this misery can help you cope with the rest.

Read More

The Migraine Relief Center Blog Is Named One of the Best Migraine and Headache Blogs of 2019

By Migraine Relief Center on July 10, 2019

The Migraine Relief Center is honored to have our blog listed as one of the best headache and migraine blogs of 2019 by Healthline, the fastest growing health information site on the internet. 

Read More

A New Drug Is Approved for the Treatment of Cluster Headaches

By Migraine Relief Center on July 9, 2019

Good news for those of you who suffer from cluster headaches. On June 4,  the FDA announced it has approved Galcanezumab, sold as Emgality by Eli Lilly and Co., for the treatment of episodic cluster headaches.READY TO EXPLORE NEW MIGRAINE SOLUTIONS?    DOWNLOAD OUR FREE MIGRAINE DIARY TODAY! »

Read More